Murder, minors, selective serotonin reuptake inhibitors, and the involuntary intoxication defense

Journal of the American Academy of Psychiatry and the Law

Volumn 26, Issue 3, 1998, Pages 487-496

  Myers, Wade C ^a,b   Vondruska, Monica A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CRIME; DRUG EFFECT; HOMICIDE; HUMAN; INTOXICATION; LAW; LEGAL ASPECT; PRESCRIPTION;

ADOLESCENT; CRIMINAL LAW; HOMICIDE; HUMANS; MALE; POISONING; SEROTONIN UPTAKE INHIBITORS;

EID: 0031694022     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Fuller RW: The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology 14:77-81, 1996
2. Hegerl U, Gallinat J, Mrowinski D: Sensory cortical processing and the biological basis of personality. Biol Psychiatry 37:467-72, 1995
3. Golden RN, Gilmore JH, Corrigan MHN, et al: Serotonin, suicide, and aggression: clinical studies. J Clin Psychiatry (suppl) 52:61-9, 1991
4. Heilegenstein JH, Beasley CM, Potvin JH: Fluoxetine not associated with increased aggression in controlled clinical trials. Int Clin Psychopharmacol 8:277-80, 1993
5. Markowitz PI: Effect of fluoxetine on selfinjurious behavior in the developmentally disabled: a preliminary study. J Clin Psychopharmacol 12:27-31, 1992
6. Merman PT, Higley JD, Faucher I, et al: Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in non-human primates. Am J Psychiatry 151:1485-91
7. Saudou F, Amara DA, Dierich A, et al: Enhanced aggressive behavior in mice lacking the 5-HT1b receptor. Science 265:1875-8, 1994
8. Fava M, Rosenbaum JH, Pava J, McCarthy MK, Steingard RJ, Bouffides E: Anger attacks in unipolar depression: 1. Clinical correlates and response to fluoxetine treatment. Am J Psychiatry 150:1158-63, 1993
9. Cocarro EF, Kavoussi RJ: Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 54: 1081-8, 1997
10. Kavoussi RJ, Liu J, Coccaro EF: An open trial of sertraline in personality-disordered patients with impulsive aggression. J Clin Psychiatry 55:137-41, 1994
11. McDougle CJ, Naylor ST, Cohen DJ, et al: A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53:980-83, 1996
12. Ranen NG, Lipsey JR, Treisman G, et al: Sertraline in the treatment of severe aggressiveness in Huntington's disease. J Neuropsychiatry Clin Neurosci 8:338-40, 1996
13. Troisi A, Vicario E, Nuccetelli F, et al: Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy. Pharmacopsychiatry 28:73-6, 1995
14. Frankenfield DL, Baker SP, Lange WR, et al: Fluoxetine and violent death in Maryland. Forensic Sci Int 64:107-17, 1994
15. Bost RO, Kemp PM: A possible association between fluoxetine use and suicide. J Anal Toxicol 16:142-5, 1992
16. Fisher S, Kent TA, Bryant SG: Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine. J Clin Psychiatry 56:288-96, 1995
17. Kindler S, Dannon PN, Iancu, I, et al: Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. Clin Neuropharmacol 20:126-9, 1997
18. Glancy GD: Antisocial ideation and activities precipitated by the administration of SSRIs. Can J Psychiatry 38:695
19. Constantino JN, Liberman M, Kincaid M: Effects of serontonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial. J Child Adolesc Psychopharmacol 7:31-44, 1997
20. Whitaker-Azmitia PM: Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev 43:553-61, 1991
21. Teicher MH, Glod C, Cole JO: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147:207-10, 1990
22. King RA, Riddle MA, Chappell PB, et al: Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 30:179-86, 1991
23. Montgomery SA, Pinder RA: Do some antidepressants promote suicide? Psychopharmacology 92:265-6, 1987
24. Capstick N: Psychiatric side-effects of clomipramine (Anafranil). J Int Med Res 1:444-8, 1973
25. Meyer L, Wiklund N, Lidberg L: Klomipramin i kombination med alkohol provocerar valdbrott? Lakartidningen 88:2768-9, 1991
26. Alarcon RD, Johnson BR, Lucas JP: Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine. J Am Acad Child Adolesc Psychiatry 30:999-1002, 1991
27. Brasic JB, Barnett JY, Sheitman BB, et al: Adverse effects of clomipramine. J Am Acad Child Adolesc Psychiatry 36:1165-6, 1997
28. Ramping D: Aggression: a paradoxical response to tricyclic antidepressants. Am J Psychiatry 135:117-18, 1978
29. Tec L: Unexpected effects in children treated with imipramine. Am J Psychiatry 120:603, 1963
30. Perkins v. United States, 228 F. 408 (4th Cir. 1915)
31. Model Penal Code, section 2.08(5)(b)
32. Bodoh v. District of Columbia Bureau of Motor Vehicle Services, 377 A.2d 1135 (D.C. 1977)
33. City of Minneapolis v. Altimus, 238 N.W.2d 851, 857 (Minn. 1976)
34. 15 FL Jur. 3d Criminal Law § 3088, 3092 (1993)
35. People v. Turner, 680 P.2d 1290, at 1292 (Colo. Ct. App. 1983)
36. Heard v. State, 887 S.W. 2d 94, 98 (Tex. App. 1994, pet. rev. refused)
37. Johnson v. State, 220 S.E.2d 448 (Ga. 1975)
38. Gilcrist v. Kincheloe, 589 F.Supp. 291, 294 (E.D. Wash. 1984), aff'd, 774 F.2d 1173 (9th Cir. 1985)
39. Jones v. State, 648 P.2d 1251 (Okla.), cert. denied, 459 U.S. 1155 (1982)
40. State v. Mriglot, 564 P.2d 784 (Wash. 1977)
41. M'Naghten Case, 8 Eng. Rep. 718, at 722 (H.L. 1843)
42. People v. Caulley, 197 Mich. App. 177 (Mich. Ct. App. 1992); 494 N.W.2d 853; 1992
43. Brancaccio v. State, 698 So.2d 597 (Fla. Dist. Ct. App. 1997)
44. Phillip E. Hassman, Annotation, When intoxication deemed involuntary so as to constitute a defense to criminal charge. 73 A.L.R.3d 195 (1976)
45. Adams v. Rios, No. 14-95-000239-CV, 1996 WL 337108 (Tex. App. June 20, 1996)
46. Forsyth v. Eli Lilly and Co., Civ. No. 95-00185ACK, 1998 U.S. Dist LEXIS 541 (D. Haw. Jan. 5, 1998)
47. Moyer KE: The Psychobiology of Aggression. New York: Harper and Row, 1976
48. Volavka J: Neurobiology of Violence. Washington, DC: American Psychiatric Press, 1995
49. Carek DJ: SSRI and sexual functioning. J Am Acad Child Adolesc Psychiatry 35:1106-7, 1996
50. Goldstein M: Brain research and violent behavior. Arch Neurol 30:1-35, 1974
51. U.S. General Accounting Office: FDA Drug Review: Postapproval Risks. Washington, DC: US General Accounting Office, April 26, 1990